Latest Security News

Page 92 of 1514
Paradigm Biopharmaceuticals has upsized a $14 million placement and launched a $2 million SPP, boosting its cash runway to around $45 million. This capital injection supports the ongoing Phase 3 trial for knee osteoarthritis, with interim results expected in Q3 2026.
Ada Torres
Ada Torres
27 Apr 2026
Flynn Gold has reported standout assay results from its Tasmanian projects, including exceptional silver-lead-zinc grades at Silver King and significant tungsten-gold mineralisation at Firetower and Warrentinna, underpinning a ramp-up in drilling and regional exploration.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Atomos has finalized its acquisition of Flanders Scientific for $2.35 million cash plus shares, funded by a new $10 million finance facility from Commonwealth Bank. The deal broadens Atomos’ professional video monitoring reach and is expected to add $1 million EBITDA before growth.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Cauldron Energy has won two co-funded grants totaling up to AUD 217,750 from the WA Government’s Exploration Incentive Scheme to advance uranium exploration at its Yanrey Project, targeting key palaeochannels including the high-priority Curtis channel.
Maxwell Dee
Maxwell Dee
27 Apr 2026
PYC Therapeutics has gained Orphan Drug Designation from the European Medicines Agency for its VP-001 candidate targeting Retinitis Pigmentosa type 11, enhancing its regulatory and commercial pathway in Europe.
Ada Torres
Ada Torres
27 Apr 2026
Babylon Pump & Power’s shares remain suspended from ASX trading as the company delays disclosure of a material transaction and capital raising, prolonging market uncertainty beyond the initial deadline.
Victor Sage
Victor Sage
27 Apr 2026
Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.
Victor Sage
Victor Sage
27 Apr 2026
SenSen Networks reported a 17% increase in annual recurring revenue to $11 million and positive operating cash flow of $0.9 million in Q3 FY26 despite supply chain disruptions delaying some projects. The company’s full-year EBITDA is expected to improve significantly over FY25.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Voltaic Strategic Resources has added a strategic exploration licence adjacent to its Ti Tree Project in Western Australia, consolidating its position along the Yinnetharra lithium corridor. The low-cost acquisition enhances its exposure to lithium and tantalum resources in a highly prospective geological setting.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Albright Metals delivers strong high-grade gold results from its Golden Pike Project in Canada while boosting its balance sheet through a $1.8 million tenement sale to Catalyst Metals, sharpening its focus on high-impact assets.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Corella Resources has agreed to acquire a majority interest in the Chobe Project, a highly prospective niobium and rare earths ground in Western Australia’s West Arunta, supported by a heavily oversubscribed $5 million capital raise.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Corella Resources has agreed to acquire a majority interest in the Chobe Project, expanding its footprint in Western Australia’s emerging rare earths and niobium hotspot. The acquisition is backed by a heavily oversubscribed $5 million capital raise.
Maxwell Dee
Maxwell Dee
27 Apr 2026